Targeting Mutant Isocitrate Dehydrogenase Acute Myeloid Leukemias by Leveraging Fructose

A Study of Asciminib Safety and Efficacy in Young Adults With Chronic Myeloid Leukemia in the Gulf Region

Conditions : Chronic Myeloid Leukemia Sponsors : Novartis Pharmaceuticals Not yet recruiting

<![CDATA[Orca-T Improves Chronic GVHD-Free Survival in Hematologic Cancers]]>

<![CDATA[Weighing Mutation Status and Fitness in Frontline AML Regimen Choice]]>

EACR and Molecular Oncology Launch New Cancer Metabolism Article Collection

European Association for Cancer Research (EACR) shared a post on LinkedIn: “Alongside our Cancer Metabolism conference (October 6th to 8th,

Targeting RBM5 may help disrupt 'undruggable' MYC in childhood leukemia

Scientists from St. Jude Children's Research Hospital and collaborators have identified the RNA-binding protein RBM5 as a potential vulnerab

Researchers uncover new T cell attack mechanism against acute myeloid leukemia

Researchers at The University of Texas MD Anderson Cancer Center have discovered a new way in which T cells attack acute myeloid leukemia (A